| P2093 | author name string | H Huang | |
| | Y Luo | |
| | Z Cai | |
| | M F Lin | |
| | J S He | |
| | Y M Tan | |
| | X H Yu | |
| | W Y Zheng | |
| | W Z Xie | |
| | J M Shi | |
| | H W Xiao | |
| | X J Ye | |
| | X Y Lai | |
| P2860 | cites work | Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. | Q51922292 |
| | TLR9 ligand enhances proliferation of rat CD4+ T cell and modulates suppressive activity mediated by CD4+ CD25+ T cell. | Q54563754 |
| | Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. | Q54620738 |
| | Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case–control disease association studies☆☆This work was supported | Q57253814 |
| | Toll-like Receptor 4 Polymorphisms and Atherogenesis | Q59273869 |
| | Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation | Q74444949 |
| | Critical role of TLR9 in acute graft-versus-host disease | Q79675206 |
| | Competing risk analysis using R: an easy guide for clinicians | Q80466908 |
| | Lymphoma immunotherapy with CpG oligodeoxynucleotides requires TLR9 either in the host or in the tumor itself | Q80736139 |
| | Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination | Q82312167 |
| | Immunosuppressive cytokine gene polymorphisms and outcome after related and unrelated hematopoietic cell transplantation in a chinese population | Q84197366 |
| | Relationship between TNFA, TNFB and TNFRII gene polymorphisms and outcome after unrelated hematopoietic cell transplantation in a Chinese population | Q84405865 |
| | Toll-like receptor 9, NOD2 and IL23R gene polymorphisms influenced outcome in AML patients transplanted from HLA-identical sibling donors | Q84561203 |
| | A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 |
| | Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection | Q24633526 |
| | Definitions of cytomegalovirus infection and disease in transplant recipients | Q28210268 |
| | Estimation of failure probabilities in the presence of competing risks: new representations of old estimators | Q33594562 |
| | Mechanisms underlying blockade of allograft acceptance by TLR ligands | Q33732481 |
| | Insufficient evidence for association of NOD2/CARD15 or other inflammatory bowel disease-associated markers on GVHD incidence or other adverse outcomes in T-replete, unrelated donor transplantation | Q33839876 |
| | The Toll receptor family and microbial recognition | Q34067869 |
| | Prevalence of CARD15/NOD2 mutations in Caucasian healthy people | Q34576207 |
| | Toll-like receptors and innate antiviral responses | Q35192578 |
| | Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides | Q35642602 |
| | Influence of coinfecting pathogens on HIV expression: evidence for a role of Toll-like receptors | Q35798758 |
| | Genetic variations of Toll-like receptor 9 predispose to systemic lupus erythematosus in Japanese population | Q35954523 |
| | Heparan sulfate, an endogenous TLR4 agonist, promotes acute GVHD after allogeneic stem cell transplantation | Q36305350 |
| | Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells | Q36371359 |
| | Genetic variations in T-cell activation and effector pathways modulate alloimmune responses after allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies | Q36662017 |
| | TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection | Q36941127 |
| | Toll-like receptor 9 (TLR9) agonists in the treatment of cancer | Q37050998 |
| | Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation | Q37130676 |
| | T-cell modulation combined with intratumoral CpG cures lymphoma in a mouse model without the need for chemotherapy | Q37157984 |
| | CpG oligodeoxynucleotides block human immunodeficiency virus type 1 replication in human lymphoid tissue infected ex vivo | Q37596720 |
| | Graft-versus-host disease: regulation by microbe-associated molecules and innate immune receptors | Q37665086 |
| | 1994 Consensus Conference on Acute GVHD Grading | Q39513397 |
| | Improved outcome of hematopoietic SCT in patients with homozygous gene variant of Toll-like receptor 9. | Q39878275 |
| | TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. | Q40313202 |
| | MyD88/TLR9 mediated immunopathology and gut microbiota dynamics in a novel murine model of intestinal graft-versus-host disease | Q42966829 |
| | MTX or mycophenolate mofetil with CsA as GVHD prophylaxis after reduced-intensity conditioning PBSCT from HLA-identical siblings | Q43169783 |
| | Putative association of a TLR9 promoter polymorphism with atopic eczema. | Q43693434 |
| | Combination of mycophenolate mofetil with cyclosporine A and methotrexate as acute GVHD prophylaxis after unrelated donor allogeneic bone marrow transplantation | Q43904474 |
| | Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model | Q44073920 |
| | Single nucleotide polymorphisms in the NOD2/CARD15 gene are associated with an increased risk of relapse and death for patients with acute leukemia after hematopoietic stem-cell transplantation with unrelated donors. | Q44848328 |
| | Cyclosporine A and mycophenolate mofetil vs cyclosporine A and methotrexate for graft-versus-host disease prophylaxis after stem cell transplantation from HLA-identical siblings | Q45132133 |
| | Herpes simplex virus type 1 activates murine natural interferon-producing cells through toll-like receptor 9. | Q45710766 |
| | Prospective trial of mycophenolate mofetil-cyclosporine A prophylaxis for acute GVHD after G-CSF stimulated allogeneic bone marrow transplantation with HLA-identical sibling donors in patients with severe aplastic anemia and hematological malignanci | Q46411065 |
| P433 | issue | 2 | |
| P304 | page(s) | 241-247 | |
| P577 | publication date | 2013-10-14 | |
| P1433 | published in | Bone Marrow Transplantation | Q4941523 |
| P1476 | title | Donor TLR9 gene tagSNPs influence susceptibility to aGVHD and CMV reactivation in the allo-HSCT setting without polymorphisms in the TLR4 and NOD2 genes | |
| P478 | volume | 49 | |